
ThermoGenesis Holdings THMO
Quarterly report 2024-Q1
added 05-17-2024
ThermoGenesis Holdings EV - Enterprise Value 2011-2026 | THMO
Annual EV - Enterprise Value ThermoGenesis Holdings
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 14 M | 10.1 M | 29.2 M | 26.2 M | 12.1 M | 50.8 M | 24.4 M | 40.3 M | 33.8 M | 17.3 M | 13.2 M | 21.3 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 50.8 M | 10.1 M | 24.4 M |
EV - Enterprise Value of other stocks in the Medical devices industry
| Issuer | EV - Enterprise Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Align Technology
ALGN
|
15.2 B | $ 176.83 | 5.97 % | $ 13.2 B | ||
|
Alphatec Holdings
ATEC
|
1.91 B | $ 11.66 | 5.71 % | $ 1.75 B | ||
|
GenMark Diagnostics, Inc.
GNMK
|
76.6 M | - | - | $ 1.77 B | ||
|
Acutus Medical
AFIB
|
40.9 M | - | -26.83 % | $ 2.62 M | ||
|
AxoGen
AXGN
|
1.55 B | $ 34.0 | 9.71 % | $ 1.57 B | ||
|
AdaptHealth Corp.
AHCO
|
3.89 B | $ 12.18 | 2.01 % | $ 1.65 B | ||
|
Allied Healthcare Products
AHPI
|
696 K | - | 3.58 % | $ 2.21 M | ||
|
Lianluo Smart Limited
LLIT
|
655 M | - | 24.59 % | $ 44.8 M | ||
|
Conformis
CFMS
|
3.84 M | - | - | $ 16.4 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
-5.83 M | - | -5.86 % | $ 30.6 M | ||
|
Bio-Rad Laboratories
BIO
|
10.1 B | $ 281.15 | 1.13 % | $ 7.93 B | ||
|
Cardiovascular Systems
CSII
|
595 M | - | 0.15 % | $ 844 M | ||
|
Cytosorbents Corporation
CTSO
|
66.9 M | $ 0.62 | 1.67 % | $ 38.6 M | ||
|
Bruker Corporation
BRKR
|
3.81 B | $ 38.25 | 4.31 % | $ 5.7 K | ||
|
Boston Scientific Corporation
BSX
|
111 B | $ 62.56 | 1.15 % | $ 92.6 B | ||
|
Dynatronics Corporation
DYNT
|
13.8 M | - | 14.99 % | $ 929 K | ||
|
Apollo Endosurgery
APEN
|
423 M | - | - | $ 475 M | ||
|
Electromed
ELMD
|
170 M | $ 24.4 | 2.61 % | $ 206 M | ||
|
Second Sight Medical Products
EYES
|
7.43 M | - | -0.97 % | $ 54.4 M | ||
|
ClearPoint Neuro
CLPT
|
340 M | $ 9.17 | 1.1 % | $ 260 M | ||
|
GBS
GBS
|
6.89 M | - | -0.57 % | $ 7.12 M | ||
|
Globus Medical
GMED
|
12.7 B | $ 91.96 | 2.13 % | $ 12.4 B | ||
|
CryoLife, Inc.
CRY
|
70.4 M | - | -4.14 % | $ 702 M | ||
|
Avinger
AVGR
|
17.3 M | - | -20.74 % | $ 369 K | ||
|
CHF Solutions, Inc.
CHFS
|
-7.7 M | - | 1.15 % | $ 34.5 M | ||
|
Inogen
INGN
|
163 M | $ 6.67 | -1.91 % | $ 177 M | ||
|
Inspire Medical Systems
INSP
|
1.78 B | $ 53.38 | -1.89 % | $ 1.57 B | ||
|
Axonics Modulation Technologies
AXNX
|
2.67 B | - | - | $ 3.31 B | ||
|
IRIDEX Corporation
IRIX
|
34.8 M | $ 1.03 | - | $ 17.4 M | ||
|
Integer Holdings Corporation
ITGR
|
4.62 B | $ 87.48 | 2.78 % | $ 3.04 B | ||
|
Invacare Corporation
IVC
|
-34.7 M | - | - | $ 24.7 M | ||
|
Aziyo Biologics
AZYO
|
-1.67 M | - | 1.37 % | $ 20.5 M | ||
|
Soliton, Inc.
SOLY
|
-100 M | - | -1.42 % | $ 435 M | ||
|
OrthoPediatrics Corp.
KIDS
|
579 M | $ 16.01 | 1.59 % | $ 376 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
7.54 B | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
427 M | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
-1.79 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
639 M | - | - | $ 111 M | ||
|
LivaNova PLC
LIVN
|
4.58 B | $ 64.66 | 1.76 % | $ 3.53 B | ||
|
LENSAR
LNSR
|
142 M | $ 5.53 | -1.78 % | $ 66.1 M | ||
|
Butterfly Network
BFLY
|
765 M | $ 4.14 | 2.22 % | $ 876 M | ||
|
Intersect ENT, Inc.
XENT
|
1.02 B | - | - | $ 955 M | ||
|
EDAP TMS S.A.
EDAP
|
139 M | $ 3.37 | -0.88 % | $ 126 M | ||
|
Myomo
MYO
|
47 M | $ 0.68 | 0.44 % | $ 28.5 M | ||
|
NanoVibronix
NAOV
|
3.17 M | - | - | $ 1.08 M | ||
|
BIOLASE
BIOL
|
26.8 M | - | -13.19 % | $ 166 K | ||
|
Delcath Systems
DCTH
|
295 M | $ 9.85 | 1.86 % | $ 353 M | ||
|
BioSig Technologies
BSGM
|
33.9 M | - | 37.08 % | $ 85.7 M | ||
|
Natus Medical Incorporated
NTUS
|
863 M | - | 1.94 % | $ 1.05 B | ||
|
Nevro Corp.
NVRO
|
441 M | - | - | $ 217 M |